{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "e85bee59-e4ef-4f79-a3f1-68d508a28c41",
   "metadata": {},
   "source": [
    "# Initial Insider Transactions\n",
    "\n",
    "This notebook shows how to use edgartools to get access to initial insider transaction data\n",
    "\n",
    "[![Open In Colab](https://colab.research.google.com/assets/colab-badge.svg)](http://colab.research.google.com/github/dgunning/edgartools/blob/main/notebooks/Initial-Insider-Transactions.ipynb)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "99659881-211a-47d3-9afd-92d24cef09f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "!pip install edgartools"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "8e71cbd3-d4c6-47a4-bc54-29fdcebfb9f0",
   "metadata": {},
   "outputs": [],
   "source": [
    "from edgar import *\n",
    "import pandas as pd\n",
    "from tqdm.auto import tqdm\n",
    "from rich import inspect, print\n",
    "pd.options.display.max_columns = None\n",
    "\n",
    "set_identity('Mike.Gardhouse@winery.com')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0699c274-6157-455c-b255-21261bd5ede6",
   "metadata": {},
   "source": [
    "## Getting Insider Filings\n",
    "\n",
    "To list insider filings on Edgar use `get_filings` and filter by form.\n",
    "\n",
    "The forms are \n",
    "\n",
    "- **Form 3** - Initial ownership\n",
    "- **Form 4** - Changes in ownership\n",
    "- **Form 5** - Annual changes in ownership"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "d4667b8d-158f-411a-8340-5be3041dca55",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "\u001b[1;38;5;245m╭─\u001b[0m\u001b[1;38;5;245m─────────────────────────────────────────────────\u001b[0m\u001b[1;38;5;245m SEC Filings \u001b[0m\u001b[1;38;5;245m─────────────────────────────────────────────────\u001b[0m\u001b[1;38;5;245m─╮\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m                                                                                                                 \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m   \u001b[1m \u001b[0m\u001b[1mForm   \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1m       CIK\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mTicker\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mCompany                               \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mFiling Date\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mAccession Number   \u001b[0m\u001b[1m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  ─────────────────────────────────────────────────────────────────────────────────────────────────────────────  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m    4        \u001b[2m \u001b[0m\u001b[2m   1770787\u001b[0m\u001b[2m \u001b[0m \u001b[33m \u001b[0m\u001b[33mTXG   \u001b[0m\u001b[33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32m10x Genomics, Inc.                    \u001b[0m\u001b[1;32m \u001b[0m  2025-03-04   \u001b[2m \u001b[0m\u001b[2m0001610717-25-0000…\u001b[0m\u001b[2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m   \u001b[1m \u001b[0m\u001b[1m4      \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m   1555279\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33mMASS  \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32m908 Devices Inc.                      \u001b[0m\u001b[1;32m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2025-03-04 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001562180-25-0020…\u001b[0m\u001b[1;2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m    4        \u001b[2m \u001b[0m\u001b[2m   1591588\u001b[0m\u001b[2m \u001b[0m \u001b[33m \u001b[0m\u001b[33mAMRK  \u001b[0m\u001b[33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32mA-Mark Precious Metals, Inc.          \u001b[0m\u001b[1;32m \u001b[0m  2025-03-04   \u001b[2m \u001b[0m\u001b[2m0001593968-25-0002…\u001b[0m\u001b[2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m   \u001b[1m \u001b[0m\u001b[1m4      \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m   1591588\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33mAMRK  \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32mA-Mark Precious Metals, Inc.          \u001b[0m\u001b[1;32m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2025-03-04 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001593968-25-0002…\u001b[0m\u001b[1;2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m    4        \u001b[2m \u001b[0m\u001b[2m   1591588\u001b[0m\u001b[2m \u001b[0m \u001b[33m \u001b[0m\u001b[33mAMRK  \u001b[0m\u001b[33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32mA-Mark Precious Metals, Inc.          \u001b[0m\u001b[1;32m \u001b[0m  2025-03-04   \u001b[2m \u001b[0m\u001b[2m0001593968-25-0002…\u001b[0m\u001b[2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m   \u001b[1m \u001b[0m\u001b[1m4      \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m   1591588\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33mAMRK  \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32mA-Mark Precious Metals, Inc.          \u001b[0m\u001b[1;32m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2025-03-04 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001593968-25-0002…\u001b[0m\u001b[1;2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m    4        \u001b[2m \u001b[0m\u001b[2m   1591588\u001b[0m\u001b[2m \u001b[0m \u001b[33m \u001b[0m\u001b[33mAMRK  \u001b[0m\u001b[33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32mA-Mark Precious Metals, Inc.          \u001b[0m\u001b[1;32m \u001b[0m  2025-03-04   \u001b[2m \u001b[0m\u001b[2m0001593968-25-0002…\u001b[0m\u001b[2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m   \u001b[1m \u001b[0m\u001b[1m4      \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m   1591588\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33mAMRK  \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32mA-Mark Precious Metals, Inc.          \u001b[0m\u001b[1;32m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2025-03-04 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001593968-25-0002…\u001b[0m\u001b[1;2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m    4        \u001b[2m \u001b[0m\u001b[2m   1591588\u001b[0m\u001b[2m \u001b[0m \u001b[33m \u001b[0m\u001b[33mAMRK  \u001b[0m\u001b[33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32mA-Mark Precious Metals, Inc.          \u001b[0m\u001b[1;32m \u001b[0m  2025-03-04   \u001b[2m \u001b[0m\u001b[2m0001593968-25-0002…\u001b[0m\u001b[2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m   \u001b[1m \u001b[0m\u001b[1m4      \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m   1580808\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33mATEN  \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;32m \u001b[0m\u001b[1;32mA10 Networks, Inc.                    \u001b[0m\u001b[1;32m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2025-03-04 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001580808-25-0000…\u001b[0m\u001b[1;2m \u001b[0m  \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m                                                                                                                 \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m╰─\u001b[0m\u001b[1;38;5;245m────────────────────────────────\u001b[0m\u001b[1;38;5;245m SEC Filings between 2025-03-04 and 2025-03-04 \u001b[0m\u001b[1;38;5;245m────────────────────────────────\u001b[0m\u001b[1;38;5;245m─╯\u001b[0m"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "filings = get_filings(form=4).head(10)\n",
    "filings"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0015370a-8cf1-4da7-ba23-f9644f4b14da",
   "metadata": {},
   "source": [
    "## Insider Filings for a Company\n",
    "\n",
    "If you are interested in insider transactions for a specific company first find the company using ticker or cik, and from there you can find the insider transactions.\n",
    "\n",
    "Let's look at insider information for **Vertex Pharmaceuticals**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "a27575cc-805e-4cfe-86c7-3ee960333463",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "\u001b[38;5;244m╭─\u001b[0m\u001b[38;5;244m──────────────────────────────\u001b[0m\u001b[38;5;244m 🏢 \u001b[0m\u001b[1;32mVERTEX PHARMACEUTICALS INC / MA\u001b[0m\u001b[38;5;244m \u001b[0m\u001b[2;38;5;244m[875320] \u001b[0m\u001b[1;33mVRTX\u001b[0m\u001b[38;5;244m \u001b[0m\u001b[38;5;244m───────────────────────────────\u001b[0m\u001b[38;5;244m─╮\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m                                                                                                                 \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m                                                                                                                 \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m╭─\u001b[0m\u001b[38;5;244m────────────────────────────────────────────────\u001b[0m\u001b[38;5;244m 📋 Entity \u001b[0m\u001b[38;5;244m────────────────────────────────────────────────\u001b[0m\u001b[38;5;244m─╮\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m                                                                                                             \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m   CIK   \u001b[1;38;5;32m875320\u001b[0m   Type   \u001b[1;33mOperating\u001b[0m   \u001b[1;33m○\u001b[0m                                                                       \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m                                                                                                             \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m                                                                                                             \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m  \u001b[1m \u001b[0m\u001b[1mCategory               \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mIndustry                         \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mFiscal Year End\u001b[0m\u001b[1m \u001b[0m                            \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m  ───────────────────────────────────────────────────────────────────────────────                            \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m   Large accelerated filer   2834: Pharmaceutical Preparations   Dec 31                                      \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m                                                                                                             \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m╭─\u001b[0m\u001b[38;5;244m──────────────────────────────────────────────\u001b[0m\u001b[38;5;244m 📈 Exchanges \u001b[0m\u001b[38;5;244m───────────────────────────────────────────────\u001b[0m\u001b[38;5;244m─╮\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m                                                                                                             \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m  \u001b[1m \u001b[0m\u001b[1mExchange\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mSymbol\u001b[0m\u001b[1m \u001b[0m                                                                                        \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m  ───────────────────                                                                                        \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m   Nasdaq    \u001b[1;33m \u001b[0m\u001b[1;33mVRTX  \u001b[0m\u001b[1;33m \u001b[0m                                                                                        \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m                                                                                                             \u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m╭─\u001b[0m\u001b[38;5;244m─\u001b[0m\u001b[38;5;244m 🏢 Business Address \u001b[0m\u001b[38;5;244m──\u001b[0m\u001b[38;5;244m─╮\u001b[0m         \u001b[38;5;244m╭─\u001b[0m\u001b[38;5;244m──\u001b[0m\u001b[38;5;244m 📫 Mailing Address \u001b[0m\u001b[38;5;244m──\u001b[0m\u001b[38;5;244m─╮\u001b[0m       \u001b[38;5;244m╭─\u001b[0m\u001b[38;5;244m 📞 Contact Information \u001b[0m\u001b[38;5;244m─╮\u001b[0m            \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m 50 NORTHERN AVENUE       \u001b[38;5;244m│\u001b[0m         \u001b[38;5;244m│\u001b[0m 50 NORTHERN AVENUE       \u001b[38;5;244m│\u001b[0m       \u001b[38;5;244m│\u001b[0m                          \u001b[38;5;244m│\u001b[0m            \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m│\u001b[0m BOSTON, MA 02210         \u001b[38;5;244m│\u001b[0m         \u001b[38;5;244m│\u001b[0m BOSTON, MA 02210         \u001b[38;5;244m│\u001b[0m       \u001b[38;5;244m│\u001b[0m  \u001b[1;38;5;249m \u001b[0m\u001b[1;38;5;249mPhone\u001b[0m\u001b[1;38;5;249m \u001b[0m  6173416393     \u001b[38;5;244m│\u001b[0m            \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m \u001b[38;5;244m╰──────────────────────────╯\u001b[0m         \u001b[38;5;244m╰──────────────────────────╯\u001b[0m       \u001b[38;5;244m│\u001b[0m                          \u001b[38;5;244m│\u001b[0m            \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m│\u001b[0m                                                                         \u001b[38;5;244m╰──────────────────────────╯\u001b[0m            \u001b[38;5;244m│\u001b[0m\n",
       "\u001b[38;5;244m╰─\u001b[0m\u001b[38;5;244m───────────────────────────────────────────────\u001b[0m\u001b[38;5;244m SEC Entity Data \u001b[0m\u001b[38;5;244m───────────────────────────────────────────────\u001b[0m\u001b[38;5;244m─╯\u001b[0m"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "company = Company(\"VRTX\")\n",
    "company"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dcc84395-d8ed-430e-a524-6148584c8fbf",
   "metadata": {},
   "source": [
    "## Initial Insiders\n",
    "\n",
    "The form 3 filings contain information about the initial positions for insiders in a company. This also means we can see roughly when persons became insiders from their initial position filings.\n",
    "\n",
    "Let's see all the company's initial filings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "59cbaffc-03f1-417f-86e6-855012fb895b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "\u001b[1;38;5;245m╭─\u001b[0m\u001b[1;38;5;245m────────────────────────────\u001b[0m\u001b[1;38;5;245m \u001b[0m\u001b[1;38;5;245mFilings for \u001b[0m\u001b[1;32mVERTEX PHARMACEUTICALS INC / MA\u001b[0m\u001b[1;2;38;5;245m [\u001b[0m\u001b[1;33m875320\u001b[0m\u001b[1;2;38;5;245m]\u001b[0m\u001b[1;38;5;245m \u001b[0m\u001b[1;38;5;245m─────────────────────────────\u001b[0m\u001b[1;38;5;245m─╮\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m                                                                                                                 \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1m \u001b[0m\u001b[1m #\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mForm    \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mDescription                                       \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mFiling Date\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mAccession Number    \u001b[0m\u001b[1m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  ─────────────────────────────────────────────────────────────────────────────────────────────────────────      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m 0\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2024-05-17   \u001b[2m \u001b[0m\u001b[2m0000875320-24-000146\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m 1\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2023-12-06 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-23-000050\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m 2\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2023-10-10   \u001b[2m \u001b[0m\u001b[2m0001209191-23-052532\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m 3\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2023-09-05 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-23-048157\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m 4\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2022-09-21   \u001b[2m \u001b[0m\u001b[2m0000899243-22-031640\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m 5\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2022-05-18 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000899243-22-018592\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m 6\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2021-05-03   \u001b[2m \u001b[0m\u001b[2m0001209191-21-029509\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m 7\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2021-03-08 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-21-018514\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m 8\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2021-02-05   \u001b[2m \u001b[0m\u001b[2m0001209191-21-008084\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m 9\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2020-06-05 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-20-034743\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m10\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2019-10-03   \u001b[2m \u001b[0m\u001b[2m0001209191-19-052174\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m11\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2019-10-03 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-19-052161\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m12\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2019-04-12   \u001b[2m \u001b[0m\u001b[2m0001209191-19-024464\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m13\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2019-02-22 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-19-012522\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m14\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2018-12-21   \u001b[2m \u001b[0m\u001b[2m0001209191-18-063964\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m15\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2018-04-02 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-18-022523\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m16\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2017-09-15   \u001b[2m \u001b[0m\u001b[2m0001209191-17-052900\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m17\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2017-06-09 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-17-038853\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m18\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2016-01-06   \u001b[2m \u001b[0m\u001b[2m0001209191-16-089937\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m19\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2015-06-08 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-15-050987\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m20\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2014-07-17   \u001b[2m \u001b[0m\u001b[2m0001209191-14-047886\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m21\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2014-05-09 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-14-032606\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m22\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2013-08-22   \u001b[2m \u001b[0m\u001b[2m0001209191-13-041734\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m23\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2012-09-18 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-12-045954\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m24\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2012-09-06   \u001b[2m \u001b[0m\u001b[2m0001209191-12-044469\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m25\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2012-07-26 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-12-039171\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m26\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2012-06-13   \u001b[2m \u001b[0m\u001b[2m0001209191-12-033674\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m27\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2012-05-29 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-12-031021\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m28\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2011-09-07   \u001b[2m \u001b[0m\u001b[2m0001209191-11-046864\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m29\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2011-05-18 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0001209191-11-029315\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m30\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2011-05-13   \u001b[2m \u001b[0m\u001b[2m0001209191-11-028288\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m31\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2010-10-14 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-10-000051\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m32\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2010-07-13   \u001b[2m \u001b[0m\u001b[2m0000875320-10-000038\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m33\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2009-12-11 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-09-000107\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m34\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2009-07-07   \u001b[2m \u001b[0m\u001b[2m0000875320-09-000055\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m35\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2009-07-07 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-09-000054\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m36\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2009-07-07   \u001b[2m \u001b[0m\u001b[2m0000875320-09-000053\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m37\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2008-09-30 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-08-000075\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m38\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2008-06-19   \u001b[2m \u001b[0m\u001b[2m0000875320-08-000044\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m39\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2007-07-24 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-07-000083\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m40\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2007-07-18   \u001b[2m \u001b[0m\u001b[2m0000875320-07-000081\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m41\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2007-07-16 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-07-000072\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m42\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2006-01-25   \u001b[2m \u001b[0m\u001b[2m0000875320-06-000005\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m43\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2005-12-15 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-05-000072\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m44\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2005-05-13   \u001b[2m \u001b[0m\u001b[2m0000875320-05-000020\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m45\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2005-02-22 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-05-000016\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m46\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2004-07-26   \u001b[2m \u001b[0m\u001b[2m0000875320-04-000085\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m47\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2004-05-10 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-04-000044\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[2m \u001b[0m\u001b[2m48\u001b[0m\u001b[2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m  2004-05-10   \u001b[2m \u001b[0m\u001b[2m0000875320-04-000043\u001b[0m\u001b[2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m  \u001b[1;2m \u001b[0m\u001b[1;2m49\u001b[0m\u001b[1;2m \u001b[0m \u001b[1;33m \u001b[0m\u001b[1;33m3       \u001b[0m\u001b[1;33m \u001b[0m \u001b[1;34m \u001b[0m\u001b[1;34mInitial statement of beneficial ownership         \u001b[0m\u001b[1;34m \u001b[0m \u001b[1m \u001b[0m\u001b[1m2004-05-10 \u001b[0m\u001b[1m \u001b[0m \u001b[1;2m \u001b[0m\u001b[1;2m0000875320-04-000042\u001b[0m\u001b[1;2m \u001b[0m      \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m                                                                                                                 \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m                                                                                                                 \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m                                                                                                                 \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m│\u001b[0m \u001b[2mShowing \u001b[0m\u001b[1;31m1\u001b[0m\u001b[2m to \u001b[0m\u001b[1;31m50\u001b[0m\u001b[2m of \u001b[0m\u001b[1m52\u001b[0m\u001b[2m filings.\u001b[0m\u001b[2m Page using \u001b[0m\u001b[1;38;5;245m← prev()\u001b[0m\u001b[2m and \u001b[0m\u001b[1;38;5;245mnext() →\u001b[0m                                                 \u001b[1;38;5;245m│\u001b[0m\n",
       "\u001b[1;38;5;245m╰─\u001b[0m\u001b[1;38;5;245m──────────────────────────────\u001b[0m\u001b[1;38;5;245m Company filings between 2003-05-23 and 2024-05-17 \u001b[0m\u001b[1;38;5;245m──────────────────────────────\u001b[0m\u001b[1;38;5;245m─╯\u001b[0m"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "initial_filings = (company.get_filings(form=3)\n",
    "                     .filter(filing_date=':2025-03-04')) # Filter up to this date to keep the notebook data stable\n",
    "initial_filings"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8156824e-2031-45c0-94cc-1c24b20d5cd9",
   "metadata": {},
   "source": [
    "There are just over 50 initial insider filings since **2004** for **VRTX**. This could be related to the SEC's **2003** rule change mandating electronic filings with previous filings being paper based. "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b5d27235-47dd-40a1-9dbc-c42908cb4d00",
   "metadata": {},
   "source": [
    "## Extracting the initial insider information\n",
    "\n",
    "To get access to the data inside the insider filings we need to loop through each filing, convert to data objects, then dataframes. Then we concatenate into a final dataframe."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "5fddd863-f73f-45bb-be0a-8bb7acc6edcf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/json": {
       "ascii": false,
       "bar_format": null,
       "colour": null,
       "elapsed": 0.002002239227294922,
       "initial": 0,
       "n": 0,
       "ncols": null,
       "nrows": 18,
       "postfix": null,
       "prefix": "",
       "rate": null,
       "total": 52,
       "unit": "it",
       "unit_divisor": 1000,
       "unit_scale": false
      },
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2a57941eecc6423e95124beaf5be03b0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "  0%|          | 0/52 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Date</th>\n",
       "      <th>Insider</th>\n",
       "      <th>Position</th>\n",
       "      <th>Total Shares</th>\n",
       "      <th>Holdings</th>\n",
       "      <th>Common Stock Holdings</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2024-05-15</td>\n",
       "      <td>Jennifer Schneider</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2023-12-05</td>\n",
       "      <td>Nancy Thornberry</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2023-10-05</td>\n",
       "      <td>Michel Lagarde</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2023-08-29</td>\n",
       "      <td>Edward Morrow Atkinson III</td>\n",
       "      <td>EVP, Chief Technical Ops. Off.</td>\n",
       "      <td>13879</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2022-09-19</td>\n",
       "      <td>Jonathan Biller</td>\n",
       "      <td>EVP and Chief Legal Officer</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2022-05-18</td>\n",
       "      <td>Suketu Upadhyay</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>2021-05-01</td>\n",
       "      <td>Kristen Ambrose</td>\n",
       "      <td>SVP &amp; Chief Accounting Officer</td>\n",
       "      <td>1394</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>2021-03-02</td>\n",
       "      <td>Joy Liu</td>\n",
       "      <td>SVP, General Counsel</td>\n",
       "      <td>13394</td>\n",
       "      <td>4</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>2021-02-03</td>\n",
       "      <td>Bastiano Sanna</td>\n",
       "      <td>EVP, Cell &amp; Genetic Therapies</td>\n",
       "      <td>21175</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>2020-06-03</td>\n",
       "      <td>Diana Mckenzie</td>\n",
       "      <td>Director</td>\n",
       "      <td>207</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>2019-10-01</td>\n",
       "      <td>Ourania Tatsis</td>\n",
       "      <td>SVP, CRO</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>2019-10-01</td>\n",
       "      <td>Carmen Bozic</td>\n",
       "      <td>EVP, GMDA</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>2019-04-10</td>\n",
       "      <td>Charles F Wagner JR</td>\n",
       "      <td>EVP and CFO</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>2019-02-21</td>\n",
       "      <td>Lloyd Carney</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>2018-12-20</td>\n",
       "      <td>Vertex Pharmaceuticals (Europe) Ltd / VERTEX P...</td>\n",
       "      <td>10% Owner</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>2018-04-01</td>\n",
       "      <td>Reshma Kewalramani</td>\n",
       "      <td>EVP and CMO</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>2017-09-13</td>\n",
       "      <td>Thomas Graney</td>\n",
       "      <td>Chief Financial Officer</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>2017-06-08</td>\n",
       "      <td>Alan M Garber</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>2016-01-04</td>\n",
       "      <td>Michael Parini</td>\n",
       "      <td>EVP &amp; CLO</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>2015-06-04</td>\n",
       "      <td>Sangeeta N. Bhatia</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>2014-07-15</td>\n",
       "      <td>Jeffrey Chodakewitz</td>\n",
       "      <td>SVP GMDA, CMO</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>2014-05-07</td>\n",
       "      <td>William D Young</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>2013-08-13</td>\n",
       "      <td>Thomas Connolly</td>\n",
       "      <td>SVP, Human Resources</td>\n",
       "      <td>150</td>\n",
       "      <td>4</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>2012-09-14</td>\n",
       "      <td>Yuchun Lee</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>2012-09-04</td>\n",
       "      <td>Stuart A Arbuckle</td>\n",
       "      <td>EVP\\Chief Commercial Officer</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>2012-07-25</td>\n",
       "      <td>Megan E Pace</td>\n",
       "      <td>SVP, Corp. Communications</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>2012-06-11</td>\n",
       "      <td>Kenneth L Horton</td>\n",
       "      <td>EVP &amp; Chief Legal Officer</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>2012-05-24</td>\n",
       "      <td>David Altshuler</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>2011-08-29</td>\n",
       "      <td>David T Howton</td>\n",
       "      <td>SVP</td>\n",
       "      <td>264</td>\n",
       "      <td>7</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>2011-05-17</td>\n",
       "      <td>Terrence C Kearney</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>2011-05-12</td>\n",
       "      <td>Margaret G Mcglynn</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>2010-10-06</td>\n",
       "      <td>Christiana Stamoulis</td>\n",
       "      <td>SVP, Corp Strategy &amp; Bus Devlp</td>\n",
       "      <td>320</td>\n",
       "      <td>4</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>2010-07-09</td>\n",
       "      <td>Wayne Joseph Riley</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>2009-12-09</td>\n",
       "      <td>Nancy Wysenski</td>\n",
       "      <td>EVP &amp; Chief Commercial Officer</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>2009-07-06</td>\n",
       "      <td>Dennis L Winger</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>2009-07-06</td>\n",
       "      <td>Dennis L Winger</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>2009-07-06</td>\n",
       "      <td>Jeffrey M Leiden</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>2008-09-29</td>\n",
       "      <td>Paul M Silva</td>\n",
       "      <td>V.P. and Corporate Controller</td>\n",
       "      <td>300</td>\n",
       "      <td>7</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>2008-06-18</td>\n",
       "      <td>Freda C Lewis-Hall</td>\n",
       "      <td>EVP, Medicines Development</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>2007-07-23</td>\n",
       "      <td>Amit Sachdev</td>\n",
       "      <td>SVP, Public Policy,Gov Affairs</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>2007-07-17</td>\n",
       "      <td>Kurt Graves</td>\n",
       "      <td>EVP, Chief Commercial Officer</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>2007-07-12</td>\n",
       "      <td>Lisa Kelly</td>\n",
       "      <td>SVP, Human Resources</td>\n",
       "      <td>360</td>\n",
       "      <td>4</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>2006-01-25</td>\n",
       "      <td>VERTEX PHARMACEUTICALS INC / MA</td>\n",
       "      <td>10% Owner</td>\n",
       "      <td>450000</td>\n",
       "      <td>4</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>2005-12-12</td>\n",
       "      <td>Richard C Garrison</td>\n",
       "      <td>SVP, Organizational Developmen</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>2005-05-11</td>\n",
       "      <td>Eugene Cordes</td>\n",
       "      <td>Director</td>\n",
       "      <td>18000</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>2005-02-15</td>\n",
       "      <td>Victor A Hartmann</td>\n",
       "      <td>EVP, Strategic &amp; Corp. Devlp.</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>2004-07-23</td>\n",
       "      <td>Matthew Emmens</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>2004-05-06</td>\n",
       "      <td>Paul A Negulescu</td>\n",
       "      <td>VP, Research</td>\n",
       "      <td>32082</td>\n",
       "      <td>27</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>2004-05-06</td>\n",
       "      <td>Eve Elizabeth Slater</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>2004-05-06</td>\n",
       "      <td>John F Niblack</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>2003-07-15</td>\n",
       "      <td>Peter Mueller</td>\n",
       "      <td>CSO &amp;amp; SVP Drug Discovery</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>2003-05-21</td>\n",
       "      <td>Eric Brandt</td>\n",
       "      <td>Director</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         Date                                            Insider  \\\n",
       "0  2024-05-15                                 Jennifer Schneider   \n",
       "1  2023-12-05                                   Nancy Thornberry   \n",
       "2  2023-10-05                                     Michel Lagarde   \n",
       "3  2023-08-29                         Edward Morrow Atkinson III   \n",
       "4  2022-09-19                                    Jonathan Biller   \n",
       "5  2022-05-18                                    Suketu Upadhyay   \n",
       "6  2021-05-01                                    Kristen Ambrose   \n",
       "7  2021-03-02                                            Joy Liu   \n",
       "8  2021-02-03                                     Bastiano Sanna   \n",
       "9  2020-06-03                                     Diana Mckenzie   \n",
       "10 2019-10-01                                     Ourania Tatsis   \n",
       "11 2019-10-01                                       Carmen Bozic   \n",
       "12 2019-04-10                                Charles F Wagner JR   \n",
       "13 2019-02-21                                       Lloyd Carney   \n",
       "14 2018-12-20  Vertex Pharmaceuticals (Europe) Ltd / VERTEX P...   \n",
       "15 2018-04-01                                 Reshma Kewalramani   \n",
       "16 2017-09-13                                      Thomas Graney   \n",
       "17 2017-06-08                                      Alan M Garber   \n",
       "18 2016-01-04                                     Michael Parini   \n",
       "19 2015-06-04                                 Sangeeta N. Bhatia   \n",
       "20 2014-07-15                                Jeffrey Chodakewitz   \n",
       "21 2014-05-07                                    William D Young   \n",
       "22 2013-08-13                                    Thomas Connolly   \n",
       "23 2012-09-14                                         Yuchun Lee   \n",
       "24 2012-09-04                                  Stuart A Arbuckle   \n",
       "25 2012-07-25                                       Megan E Pace   \n",
       "26 2012-06-11                                   Kenneth L Horton   \n",
       "27 2012-05-24                                    David Altshuler   \n",
       "28 2011-08-29                                     David T Howton   \n",
       "29 2011-05-17                                 Terrence C Kearney   \n",
       "30 2011-05-12                                 Margaret G Mcglynn   \n",
       "31 2010-10-06                               Christiana Stamoulis   \n",
       "32 2010-07-09                                 Wayne Joseph Riley   \n",
       "33 2009-12-09                                     Nancy Wysenski   \n",
       "34 2009-07-06                                    Dennis L Winger   \n",
       "35 2009-07-06                                    Dennis L Winger   \n",
       "36 2009-07-06                                   Jeffrey M Leiden   \n",
       "37 2008-09-29                                       Paul M Silva   \n",
       "38 2008-06-18                                 Freda C Lewis-Hall   \n",
       "39 2007-07-23                                       Amit Sachdev   \n",
       "40 2007-07-17                                        Kurt Graves   \n",
       "41 2007-07-12                                         Lisa Kelly   \n",
       "42 2006-01-25                    VERTEX PHARMACEUTICALS INC / MA   \n",
       "43 2005-12-12                                 Richard C Garrison   \n",
       "44 2005-05-11                                      Eugene Cordes   \n",
       "45 2005-02-15                                  Victor A Hartmann   \n",
       "46 2004-07-23                                     Matthew Emmens   \n",
       "47 2004-05-06                                   Paul A Negulescu   \n",
       "48 2004-05-06                               Eve Elizabeth Slater   \n",
       "49 2004-05-06                                     John F Niblack   \n",
       "50 2003-07-15                                      Peter Mueller   \n",
       "51 2003-05-21                                        Eric Brandt   \n",
       "\n",
       "                          Position  Total Shares  Holdings  \\\n",
       "0                         Director             0         0   \n",
       "1                         Director             0         0   \n",
       "2                         Director             0         0   \n",
       "3   EVP, Chief Technical Ops. Off.         13879         1   \n",
       "4      EVP and Chief Legal Officer             0         0   \n",
       "5                         Director             0         0   \n",
       "6   SVP & Chief Accounting Officer          1394         1   \n",
       "7             SVP, General Counsel         13394         4   \n",
       "8    EVP, Cell & Genetic Therapies         21175         1   \n",
       "9                         Director           207         1   \n",
       "10                        SVP, CRO             0         6   \n",
       "11                       EVP, GMDA             0         2   \n",
       "12                     EVP and CFO             0         0   \n",
       "13                        Director             0         0   \n",
       "14                       10% Owner             0         1   \n",
       "15                     EVP and CMO             0         2   \n",
       "16         Chief Financial Officer             0         0   \n",
       "17                        Director             0         0   \n",
       "18                       EVP & CLO             0         0   \n",
       "19                        Director             0         0   \n",
       "20                   SVP GMDA, CMO             0         2   \n",
       "21                        Director             0         0   \n",
       "22            SVP, Human Resources           150         4   \n",
       "23                        Director             0         0   \n",
       "24    EVP\\Chief Commercial Officer             0         0   \n",
       "25       SVP, Corp. Communications             0         5   \n",
       "26       EVP & Chief Legal Officer             0         0   \n",
       "27                        Director             0         1   \n",
       "28                             SVP           264         7   \n",
       "29                        Director             0         1   \n",
       "30                        Director             0         1   \n",
       "31  SVP, Corp Strategy & Bus Devlp           320         4   \n",
       "32                        Director             0         1   \n",
       "33  EVP & Chief Commercial Officer             0         1   \n",
       "34                        Director             0         1   \n",
       "35                        Director             0         1   \n",
       "36                        Director             0         1   \n",
       "37   V.P. and Corporate Controller           300         7   \n",
       "38      EVP, Medicines Development             0         1   \n",
       "39  SVP, Public Policy,Gov Affairs             0         1   \n",
       "40   EVP, Chief Commercial Officer             0         1   \n",
       "41            SVP, Human Resources           360         4   \n",
       "42                       10% Owner        450000         4   \n",
       "43  SVP, Organizational Developmen             0         2   \n",
       "44                        Director         18000         2   \n",
       "45   EVP, Strategic & Corp. Devlp.             0         2   \n",
       "46                        Director             0         1   \n",
       "47                    VP, Research         32082        27   \n",
       "48                        Director             0         1   \n",
       "49                        Director             0         1   \n",
       "50    CSO &amp; SVP Drug Discovery             0         0   \n",
       "51                        Director             0         0   \n",
       "\n",
       "    Common Stock Holdings  \n",
       "0                       0  \n",
       "1                       0  \n",
       "2                       0  \n",
       "3                       1  \n",
       "4                       0  \n",
       "5                       0  \n",
       "6                       1  \n",
       "7                       1  \n",
       "8                       1  \n",
       "9                       1  \n",
       "10                      4  \n",
       "11                      1  \n",
       "12                      0  \n",
       "13                      0  \n",
       "14                      1  \n",
       "15                      1  \n",
       "16                      0  \n",
       "17                      0  \n",
       "18                      0  \n",
       "19                      0  \n",
       "20                      1  \n",
       "21                      0  \n",
       "22                      2  \n",
       "23                      0  \n",
       "24                      0  \n",
       "25                      1  \n",
       "26                      0  \n",
       "27                      1  \n",
       "28                      2  \n",
       "29                      1  \n",
       "30                      1  \n",
       "31                      2  \n",
       "32                      1  \n",
       "33                      1  \n",
       "34                      1  \n",
       "35                      1  \n",
       "36                      1  \n",
       "37                      4  \n",
       "38                      1  \n",
       "39                      1  \n",
       "40                      1  \n",
       "41                      2  \n",
       "42                      2  \n",
       "43                      1  \n",
       "44                      1  \n",
       "45                      1  \n",
       "46                      0  \n",
       "47                      5  \n",
       "48                      0  \n",
       "49                      0  \n",
       "50                      0  \n",
       "51                      0  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "insider_data = []\n",
    "\n",
    "for filing in tqdm(initial_filings):\n",
    "    # Convert to data object\n",
    "    form3 = filing.obj()\n",
    "    # Get the data in a dataframe. Set detailed = False to get 1 summary row\n",
    "    df = form3.to_dataframe(detailed=False)\n",
    "\n",
    "    insider_data.append(df)\n",
    "\n",
    "insider_data = (pd.concat(insider_data, ignore_index=True)\n",
    "                    .drop(columns=['Form', 'Issuer', 'Ticker', 'Remarks',\n",
    "                                   'Has Derivatives', 'Derivative Holdings']) \n",
    "                    .reset_index(drop=True)\n",
    "                    \n",
    "               )\n",
    "insider_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "abfefaac-c52c-42a3-931a-cb7e4268451d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "╭──────── \u001b[1mForm 3 \u001b[0m\u001b[1;32mVERTEX PHARMACEUTICALS INC / MA\u001b[0m \u001b[2m[875320] \u001b[0m\u001b[1;33mVRTX\u001b[0m ─────────╮\n",
       "│                                                                       │\n",
       "│  \u001b[2m \u001b[0m\u001b[2mAccession Number    \u001b[0m\u001b[2m \u001b[0m \u001b[2m \u001b[0m\u001b[2mFiling Date\u001b[0m\u001b[2m \u001b[0m \u001b[2m \u001b[0m\u001b[2mPeriod of Report\u001b[0m\u001b[2m \u001b[0m \u001b[2m \u001b[0m\u001b[2mDocuments\u001b[0m\u001b[2m \u001b[0m  │\n",
       "│  ───────────────────────────────────────────────────────────────────  │\n",
       "│   \u001b[1;38;5;39m0000875320-09-000055\u001b[0m   \u001b[1m2009-07-07 \u001b[0m   \u001b[1m2009-07-06      \u001b[0m   2           │\n",
       "│                                                                       │\n",
       "│                                                                       │\n",
       "│                                                                       │\n",
       "│                                                                       │\n",
       "╰──────────────\u001b[2m Initial statement of beneficial ownership \u001b[0m──────────────╯"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "initial_filings[34]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "69cea686-ad45-4cbe-b44f-fa154a7c0518",
   "metadata": {},
   "source": [
    "## Viewing specific insider filings"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9e437c7e-43f7-4a6a-8aa2-105fabe3ffde",
   "metadata": {},
   "source": [
    "#### Jennifer Schneider (Director)\n",
    "Jennifer Schneider's initial filing indicated no holdings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "3338fd10-1c5e-4465-afb8-3cc7dacd1334",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "╭──────────────── \u001b[1mInitial Beneficial Ownership\u001b[0m ────────────────╮\n",
       "│ \u001b[1;34mInsider: \u001b[0m\u001b[1;34m \u001b[0mJennifer Schneider                                 │\n",
       "│ \u001b[1;34mPosition:\u001b[0m\u001b[1;34m \u001b[0mDirector                                           │\n",
       "│ \u001b[1;34mCompany: \u001b[0m\u001b[1;34m \u001b[0mVERTEX PHARMACEUTICALS INC / MA (VRTX)             │\n",
       "│ \u001b[1;34mDate:    \u001b[0m\u001b[1;34m \u001b[0m2024-05-15                                         │\n",
       "│ \u001b[1;34mForm:    \u001b[0m\u001b[1;34m \u001b[0mForm 3 (Initial Statement of Beneficial Ownership) │\n",
       "│ \u001b[3mNo Securities Beneficially Owned\u001b[0m                             │\n",
       "│ \u001b[3mRemarks: Exhibit 24 - Power of Attorney\u001b[0m                      │\n",
       "╰──────────────────────────────────────────────────────────────╯"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "initial_filings[0].obj()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b1583fb0-d8de-4c20-81bd-9e691026774c",
   "metadata": {},
   "source": [
    "#### Edward Morrow Atkinson III (EVP)\n",
    "\n",
    "Here we see **Edward Morrow Atkinson III** initial position in common stock"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "15443079-e081-4d03-a72b-a32d88b83ffa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "╭──────────────── \u001b[1mInitial Beneficial Ownership\u001b[0m ────────────────╮\n",
       "│ \u001b[1;34mInsider: \u001b[0m\u001b[1;34m \u001b[0mEdward Morrow Atkinson III                         │\n",
       "│ \u001b[1;34mPosition:\u001b[0m\u001b[1;34m \u001b[0mEVP, Chief Technical Ops. Off.                     │\n",
       "│ \u001b[1;34mCompany: \u001b[0m\u001b[1;34m \u001b[0mVERTEX PHARMACEUTICALS INC / MA (VRTX)             │\n",
       "│ \u001b[1;34mDate:    \u001b[0m\u001b[1;34m \u001b[0m2023-08-29                                         │\n",
       "│ \u001b[1;34mForm:    \u001b[0m\u001b[1;34m \u001b[0mForm 3 (Initial Statement of Beneficial Ownership) │\n",
       "│ \u001b[1m        Common Stock Holdings        \u001b[0m                        │\n",
       "│                                                              │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mSecurity    \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mShares\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mOwnership\u001b[0m\u001b[1m \u001b[0m                         │\n",
       "│  ───────────────────────────────────                         │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mCommon Stock\u001b[0m\u001b[1m \u001b[0m  13,879   Direct                             │\n",
       "│                                                              │\n",
       "│ \u001b[3mRemarks: Exhibit 24 - Power of Attorney\u001b[0m                      │\n",
       "╰──────────────────────────────────────────────────────────────╯"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "initial_filings[3].obj()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "495a7c95-5459-4d20-98c1-6cbe2e8d35b9",
   "metadata": {},
   "source": [
    "#### Ourania Tatsis\n",
    "This filing by Ourania Tatsis has both Common Stock and Derivative Holdings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "3352afe6-5914-4afb-a477-f23170feebcc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "╭────────────────────────────────── \u001b[1mInitial Beneficial Ownership\u001b[0m ───────────────────────────────────╮\n",
       "│ \u001b[1;34mInsider: \u001b[0m\u001b[1;34m \u001b[0mOurania Tatsis                                                                          │\n",
       "│ \u001b[1;34mPosition:\u001b[0m\u001b[1;34m \u001b[0mSVP, CRO                                                                                │\n",
       "│ \u001b[1;34mCompany: \u001b[0m\u001b[1;34m \u001b[0mVERTEX PHARMACEUTICALS INC / MA (VRTX)                                                  │\n",
       "│ \u001b[1;34mDate:    \u001b[0m\u001b[1;34m \u001b[0m2019-10-01                                                                              │\n",
       "│ \u001b[1;34mForm:    \u001b[0m\u001b[1;34m \u001b[0mForm 3 (Initial Statement of Beneficial Ownership)                                      │\n",
       "│ \u001b[1m         Common Stock Holdings          \u001b[0m                                                          │\n",
       "│                                                                                                   │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mSecurity    \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1m   Shares\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mOwnership\u001b[0m\u001b[1m \u001b[0m                                                           │\n",
       "│  ──────────────────────────────────────                                                           │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mCommon Stock\u001b[0m\u001b[1m \u001b[0m  3500 [F1]   Direct                                                               │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mCommon Stock\u001b[0m\u001b[1m \u001b[0m  1876 [F2]   Direct                                                               │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mCommon Stock\u001b[0m\u001b[1m \u001b[0m   632 [F3]   Direct                                                               │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mCommon Stock\u001b[0m\u001b[1m \u001b[0m  1876 [F4]   Direct                                                               │\n",
       "│                                                                                                   │\n",
       "│ \u001b[1m                                      Derivative Securities                                      \u001b[0m │\n",
       "│                                                                                                   │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mSecurity                   \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mUnderlying  \u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mShares\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mExercise Price\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mExpiration\u001b[0m\u001b[1m \u001b[0m \u001b[1m \u001b[0m\u001b[1mOwnership\u001b[0m\u001b[1m \u001b[0m  │\n",
       "│  ───────────────────────────────────────────────────────────────────────────────────────────────  │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mStock Option (Right to Buy)\u001b[0m\u001b[1m \u001b[0m \u001b[3m \u001b[0m\u001b[3mCommon Stock\u001b[0m\u001b[3m \u001b[0m   8,938  \u001b[32m \u001b[0m\u001b[32m       $187.53\u001b[0m\u001b[32m \u001b[0m \u001b[2m \u001b[0m\u001b[2m2029-02-05\u001b[0m\u001b[2m \u001b[0m  Direct      │\n",
       "│  \u001b[1m \u001b[0m\u001b[1mStock Option (Right to Buy)\u001b[0m\u001b[1m \u001b[0m \u001b[3m \u001b[0m\u001b[3mCommon Stock\u001b[0m\u001b[3m \u001b[0m   6,522  \u001b[32m \u001b[0m\u001b[32m       $155.57\u001b[0m\u001b[32m \u001b[0m \u001b[2m \u001b[0m\u001b[2m2028-02-05\u001b[0m\u001b[2m \u001b[0m  Direct      │\n",
       "│                                                                                                   │\n",
       "╰───────────────────────────────────────────────────────────────────────────────────────────────────╯"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "initial_filings[10].obj()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
